Lazard Asset Management LLC Alkermes Plc. Transaction History

Lazard Asset Management LLC

$70 Billion
Q3 2025

A detailed history of Lazard Asset Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 25,723 shares of ALKS stock, worth $746,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,723

Previous 23,753 8.29%

Holding current value

$746,995

Previous $679,000 13.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$26.13 - $30.46 $51,476 - $60,006	1,970 Added 8.29%	25,723 $771,000
Q2 2025 Aug 14, 2025	SELL	$26.59 - $32.65 $3.09 Million - $3.79 Million	-116,128 Reduced 83.02%	23,753 $679,000
Q1 2025 May 15, 2025	BUY	$28.08 - $36.0 $1.31 Million - $1.68 Million	46,735 Added 50.17%	139,881 $4.62 Million
Q4 2024 Feb 14, 2025	SELL	$25.7 - $31.46 $73,322 - $89,755	-2,853 Reduced 2.97%	93,146 $2.68 Million
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $282,746 - $350,822	12,288 Added 14.68%	95,999 $2.69 Million

Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $153,394 - $180,029	6,609 Added 8.57%	83,711 $2.02 Million
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $1.77 Million - $2.18 Million	66,890 Added 655.01%	77,102 $2.09 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $53,844 - $66,078	2,304 Added 29.14%	10,212 $283,000
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $214,860 - $252,818	7,908 New	7,908 $221,000
Q2 2022 Aug 09, 2022	SELL	$26.4 - $30.54 $72,283 - $83,618	-2,738 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $63,165 - $76,636	2,738 New	2,738 $72,000
Q4 2021 Feb 09, 2022	SELL	$21.47 - $32.08 $52,236 - $78,050	-2,433 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $56,859 - $78,172	2,433 New	2,433 $75,000
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $50,077 - $63,800	-2,750 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$15.39 - $22.1 $42,322 - $60,775	2,750 New	2,750 $54,000
Q3 2020 Nov 13, 2020	SELL	$16.16 - $20.66 $64,025 - $81,854	-3,962 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$13.31 - $19.41 $34,246 - $49,941	-2,573 Reduced 39.37%	3,962 $76,000
Q1 2020 May 14, 2020	BUY	$13.06 - $21.24 $85,347 - $138,803	6,535 New	6,535 $94,000

Others Institutions Holding ALKS

# of Institutions

401

Shares Held

176M

Call Options Held

901K

Put Options Held

400K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.77B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Alkermes Plc. Transaction History